Gendicine
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Gendicine, covering 2012-04-09 to 2015-05-06. Get the full timeline:
Most recent: Clinical Trial Update: p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer [Phase 2]